ÇINAR, G. Et Al. 2018. Tenofovir versus tenofovir plus entecavir in the treatment of chroınic hepatitis B patients with poor efficacy of nucleoside/nucleotide agents. 16 th European Meeting on HIV Antiviral Drug Resistance .

ÇINAR, G., yılmaz karadağ, f., Kader, c., korkmaz, f., tülek, n., SÜER, H. K., ... BATIREL, A.(2018). Tenofovir versus tenofovir plus entecavir in the treatment of chroınic hepatitis B patients with poor efficacy of nucleoside/nucleotide agents . 16 th European Meeting on HIV Antiviral Drug Resistance

ÇINAR, GÜLE Et Al. "Tenofovir versus tenofovir plus entecavir in the treatment of chroınic hepatitis B patients with poor efficacy of nucleoside/nucleotide agents," 16 th European Meeting on HIV Antiviral Drug Resistance, 2018

ÇINAR, GÜLE Et Al. "Tenofovir versus tenofovir plus entecavir in the treatment of chroınic hepatitis B patients with poor efficacy of nucleoside/nucleotide agents." 16 th European Meeting on HIV Antiviral Drug Resistance , 2018

ÇINAR, G. Et Al. (2018) . "Tenofovir versus tenofovir plus entecavir in the treatment of chroınic hepatitis B patients with poor efficacy of nucleoside/nucleotide agents." 16 th European Meeting on HIV Antiviral Drug Resistance .

@conferencepaper{conferencepaper, author={GÜLE ÇINAR Et Al. }, title={Tenofovir versus tenofovir plus entecavir in the treatment of chroınic hepatitis B patients with poor efficacy of nucleoside/nucleotide agents}, congress name={16 th European Meeting on HIV Antiviral Drug Resistance}, city={}, country={}, year={2018}}